- Home
- CRNX vs EME Comparison
CRNX vs EME Comparison
Compare CRNX & EME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRNX | EME |
|---|---|---|
| Founded | 2008 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Engineering & Construction |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 27.7B |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | CRNX | EME |
|---|---|---|
| Price | $50.13 | $618.92 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 6 |
| Target Price | $71.00 | ★ $693.60 |
| AVG Volume (30 Days) | ★ 1.1M | 397.0K |
| Earning Date | 11-06-2025 | 10-30-2025 |
| Dividend Yield | N/A | ★ 0.16% |
| EPS Growth | N/A | ★ 26.22 |
| EPS | N/A | ★ 24.83 |
| Revenue | $1,535,000.00 | ★ $16,243,320,000.00 |
| Revenue This Year | $425.31 | $16.21 |
| Revenue Next Year | $943.50 | $6.58 |
| P/E Ratio | ★ N/A | $25.12 |
| Revenue Growth | ★ 47.74 | 14.11 |
| 52 Week Low | $24.10 | $320.89 |
| 52 Week High | $60.25 | $778.64 |
Technical Indicators
Market Signals| Indicator | CRNX | EME |
|---|---|---|
| Relative Strength Index (RSI) | 72.28 | 47.57 |
| Support Level | $46.49 | $611.15 |
| Resistance Level | $49.29 | $642.20 |
| Average True Range (ATR) | 1.96 | 20.01 |
| MACD | 0.41 | 4.50 |
| Stochastic Oscillator | 94.31 | 61.35 |
Price Performance
Historical ComparisonAbout CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
About EME EMCOR Group Inc.
EMCOR Group Inc is a specialty contractor in the United States and a provider of electrical and mechanical construction and facilities services, building services, and industrial services. Its services are provided to a broad range of commercial, technology, manufacturing, industrial, healthcare, utility, and institutional customers through approximately 100 operating subsidiaries. The company's operating subsidiaries are organized into reportable segments: United States mechanical construction and facilities services, which derives key revenue; United States electrical construction and facilities services; United States building services; United States industrial services; and United Kingdom building services. Geographically, its key revenue is derived from the United States.